corporate_fare

Compass Pathfinder Limited

Address
3rd Floor, 1 Ashley Road

Sponsor Overview

assignment
1
sponsored trial
science
1
molecule
location_city
34
research centres
public
9
countries
person_search
35
investigators

Specializations

Psychiatric Disorders

Compass Pathfinder Limited is focused on clinical research in treatment-resistant depression, with activity centered on adult patients whose depressive symptoms remain difficult to manage.

  • Depressive symptom improvement
  • Treatment-resistant depression
  • Adult mental health

The sponsor’s research interest is concentrated on depression within the broader field of psychiatry, reflecting a therapeutic focus on persistent mood disorders and unmet clinical need.

Psychological Support in Mental Health Care

Its clinical research includes the use of psychological support alongside treatment approaches for major depressive symptoms, highlighting the integration of mental health support within interventional care.

  • Psychological support
  • Adjunctive mental health care
  • Symptom-focused psychiatric treatment

This area places emphasis on the therapeutic management of mood disorders and the clinical role of supportive care in depression treatment.

Neuroscience and Brain Health

The sponsor’s research activity is also aligned with neuroscience, particularly conditions affecting emotional regulation, cognition, and overall brain health.

  • Neuropsychiatric conditions
  • Brain function
  • Emotional regulation

Its clinical interest lies in disorders where central nervous system pathways are implicated in persistent depressive illness.

Mental Health Therapeutics

Compass Pathfinder Limited is engaged in research related to mental health therapeutics, with particular attention to approaches intended to address ongoing depressive symptoms in adults.

  • Adult psychiatry
  • Depression therapeutics
  • Persistent mood symptoms

The sponsor’s clinical portfolio is concentrated on therapeutic innovation in psychiatry, especially for patients with limited response to existing depression treatments.

Sponsored Trials

Trial Name Country Status
Efficacy and Safety of Psilocybin (COMP360) in Adults with Treatment-Resistant Depression: A Phase III Randomized, Double-Blind, Controlled TrialCzechia CzechiaDenmark DenmarkFrance FranceGermany GermanyIreland IrelandPoland PolandSpain SpainSweden SwedenThe Netherlands The NetherlandsNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 1 total (0% not shared with other sponsors)

This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 34 sites collaborated multiple times

This sponsor has worked with 34 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Mental Disorders1 trial
    150 other sponsors

Partnered Research Centres

34 centres
location_city
assignment39
A-Shine s.r.o.
Address
Sumavska 2, Vychodni Predmesti, 301 00 Pilsen
Learn morearrow_forward
location_city
assignment31
Assistance Publique Hopitaux De Paris
Address
Num Voie 47 A 83, 47 Boulevard De L Hopital, 75013 Paris
Learn morearrow_forward
location_city
assignment302
Centre Hospitalier Universitaire De Nimes
Address
4 Place Du Professeur Robert Debre, Bp 40026, 30029 Nîmes
Learn morearrow_forward
location_city
assignment126
Centrum Badan Klinicznych Pi-House Sp. z o.o.
Address
Ul. Na Zaspe 3, 80-546 Gdansk
Learn morearrow_forward
location_city
assignment1047
Charite Universitaetsmedizin Berlin KöR
Address
Hindenburgdamm 30, Lichterfelde, 12203 Berlin
Learn morearrow_forward
location_city
assignment1
Clinica Delos S.L.P.
Address
Calle Bigai 11 Entresuelo 2, 08022 Barcelona
Learn morearrow_forward
Page 1 of 6

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Compass Pathfinder Limited.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.